Cardiol Therapeutics Is Ready To Capitalize On The Global CBD Opportunity

In late April, we highlighted Cardiol Therapeutics (Cardiol) (CRDL: TSX) (CRTPF: OTC) as a company that has been ahead of the curve with the legal…

In late April, we highlighted Cardiol Therapeutics (Cardiol) (CRDL: TSX) (CRTPF: OTC) as a company that has been ahead of the curve with the legal cannabis industry and has been focused on the production of 100% pure pharmaceutical-grade cannabidiol (CBD). Cardiol has been able to differentiate itself from other CBD companies by focusing of the […]

The post Cardiol Therapeutics Is Ready To Capitalize On The Global CBD Opportunity appeared first on Technical420.

Leave a Reply

Your email address will not be published. Required fields are marked *